An extension or re-treatment study of bortezomib to patients with relapsed or refractory multiple myeloma
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 15 Dec 2009 Actual patient number (13) added as reported by ClinicalTrials.gov.
- 19 Oct 2007 Status changed from in progress to completed.
- 25 Oct 2005 New trial record.